A Study of MK-3415, MK-6072, and MK-3415A in Participants Receiving Antibiotic Therapy for Clostridium Difficile Infection (MK-3415A-001 AM2) (MODIFY I)
This study is currently recruiting participants.
Verified April 2013 by Merck
Study NCT01241552
Information provided by Merck
First Received on November 12, 2010.
Last Updated on April 15, 2013
History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
